PURA Gene: Transcriptional Activator and RNA Binding Protein
Comprehensive biomedical resource for PURA gene, associated with PURA syndrome and neurodevelopmental disorders.
Gene Information Card
| Symbol | PURA |
|---|---|
| Full Name | purine rich element binding protein A |
| Gene Type | protein coding |
| Chromosomal Location | 5q31.2 |
| NCBI Gene ID | 5813 ncbi.nlm.nih.gov/gene/5813 |
| Ensembl ID | ENSG00000130176 |
| UniProt ID | Q00577 |
| OMIM ID | 600473 |
| HGNC ID | 9071 |
| Aliases | PUR1, PURA1, PURB, PUR-alpha |
Description
The PURA gene encodes a highly conserved DNA- and RNA-binding protein that functions as a transcriptional activator and regulator of mRNA translation. It binds to purine-rich elements in gene promoters and to specific RNA sequences, influencing cell cycle progression, neuronal differentiation, and synaptic function. Heterozygous loss-of-function mutations in PURA cause PURA syndrome, a neurodevelopmental disorder characterized by intellectual disability, hypotonia, and epilepsy.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| PURA syndrome (neurodevelopmental disorder) | Heterozygous loss-of-function mutations (nonsense, frameshift, missense) reduce PURA protein levels or disrupt DNA/RNA binding, impairing neuronal gene expression and synaptic plasticity. | ClinVar, OMIM #616158 |
| Intellectual disability, autosomal dominant 31 | De novo mutations in PURA cause a syndromic form of intellectual disability with motor delay and speech impairment. | OMIM #616158, NCBI Gene |
| Epileptic encephalopathy, early infantile | Severe PURA mutations are associated with early-onset seizures and developmental regression. | ClinVar, PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain (cerebral cortex) | 12.5 | Medium |
| Heart | 8.3 | Medium |
| Skeletal muscle | 7.1 | Medium |
| Liver | 4.2 | Low |
| Kidney | 5.6 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 10.2 | Neuronal model |
| HeLa (cervical carcinoma) | 8.9 | Epithelial |
| HEK293 (embryonic kidney) | 7.5 | Common expression system |
| K562 (leukemia) | 6.1 | Myeloid |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.697C>T (p.Arg233*) | Nonsense | Rare | Loss of function; truncation of PURA protein |
| c.571_574del (p.Glu191Argfs*12) | Frameshift | Rare | Loss of function; premature termination |
| c.389G>A (p.Arg130Gln) | Missense | Rare | Impaired DNA binding; reduced transcriptional activity |
| c.1A>G (p.Met1?) | Start loss | Rare | Loss of translation initiation; complete loss of protein |
Mutation functional classification
Loss of Function (LOF)
Majority of pathogenic mutations (nonsense, frameshift, start loss) lead to haploinsufficiency, reducing PURA protein levels below 50%.
Gain of Function (GOF)
No evidence for gain-of-function mutations in PURA.
Dominant Negative (DN)
Some missense mutations (e.g., p.Arg130Gln) may exert dominant-negative effects by interfering with wild-type PURA binding to DNA/RNA.
View complete mutation data:
Gene Ontology (GO)
| • DNA binding (GO:0003677) | • RNA binding (GO:0003723) |
| • transcription cis-regulatory region binding (GO:0000976) | • mRNA binding (GO:0003729) |
| • regulation of transcription by RNA polymerase II (GO:0006357) | • positive regulation of transcription |
| • DNA-templated (GO:0045893) | • mRNA stabilization (GO:0048255) |
| • cell cycle (GO:0007049) | • nervous system development (GO:0007399) |
Pathways
• Transcriptional regulation by PURA (Reactome: R-HSA-212436)
• mRNA stability regulation (Reactome: R-HSA-8953854)
• Neuronal differentiation (KEGG: hsa04728)
Protein Summary
PURA is a 322-amino acid protein (UniProt Q00577) containing two N-terminal DNA-binding domains and a C-terminal RNA-binding domain. It forms homodimers and heterodimers with PURB, binding to single-stranded purine-rich DNA sequences (e.g., PUR elements) and to specific mRNA targets (e.g., tau, MAP2). PURA regulates transcription of genes involved in cell cycle (e.g., cyclin B1) and neuronal development, and also controls mRNA translation and stability. Loss of PURA function leads to dysregulation of synaptic genes and neuronal excitability, underlying the pathogenesis of PURA syndrome.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PURA Knockout HEK293 Cell Line | EDJ-KQ5608 | Human | 5813 | Details Get a Quote |
| PURA Knockout HCT 116 Cell Line | EDJ-KQ27634 | Human | 5813 | Details Get a Quote |
| PURA Knockout A-549 Cell Line | EDJ-KQ28891 | Human | 5813 | Details Get a Quote |
| PURA Knockout HeLa Cell Line | EDJ-KQ28893 | Human | 5813 | Details Get a Quote |
| PURA Knockout hIPSC-ZZ Cell Line | EDC07986 | Human | 5813 | Details Get a Quote |
Displaying Records 1 To 5 Of 5 Records